Form D · Other Health Care
Theracaine LLC
San Francisco, CA · CIK 0001675120
Offering snapshot reported May 25, 2016 · SEC filing
- Reported sold
- $1.35M Offering amount: $1.35M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 3, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 25, 2016 | Initial | $1,350,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-263797
Source: Form D, filed May 25, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Craig Landau | Director |
| Jeffrey Lightcap | Director |
| Sam Sawan | Director |
| Ajit Shah | Director |
| Tadmor Shalon | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
150 Post Street Suite 650
San Francisco, CA, 94108
San Francisco, CA, 94108